Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
Current Protocols in Pharmacology
|
March 21, 2016
Overview of Genetically Engineered Mouse Models of Distinct Breast Cancer Subtypes
Jerry Usary, David Brian Darr, Adam D Pfefferle, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
May 17, 2012
Dietary energy balance modulates epithelial-to-mesenchymal transition and tumor progression in murine claudin-low and basal-like mammary tumor models
Sarah M Dunlap, Lucia J Chiao, Leticia Nogueira, et al.
Genes & Cancer
|
March 15, 2013
Targeting the PyMT Oncogene to Diverse Mammary Cell Populations Enhances Tumor Heterogeneity and Generates Rare Breast Cancer Subtypes
Brittni A Smith, Dawne N Shelton, Collin Kieffer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2006
Estrogen-regulated genes predict survival in hormone receptor-positive breast cancers
Daniel S Oh, Melissa A Troester, Jerry Usary, et al.
Cancer Cell
|
May 5, 2009
CDK inhibitor p18(INK4c) is a downstream target of GATA3 and restrains mammary luminal progenitor cell proliferation and tumorigenesis
Xin-Hai Pei, Feng Bai, Matthew D Smith, et al.
NPJ Breast Cancer
|
July 28, 2017
Metabolic reprogramming underlies metastatic potential in an obesity-responsive murine model of metastatic triple negative breast cancer
Ciara H O'Flanagan, Emily L Rossi, Shannon B McDonell, et al.
Plos One
|
June 16, 2011
The role of calcineurin/NFAT in SFRP2 induced angiogenesis--a rationale for breast cancer treatment with the calcineurin inhibitor tacrolimus
Sharareh Siamakpour-Reihani, Joseph Caster, Desh Bandhu Nepal, et al.
Breast Cancer Research and Treatment
|
November 29, 2018
A mouse model featuring tissue-specific deletion of p53 and Brca1 gives rise to mammary tumors with genomic and transcriptomic similarities to human basal-like breast cancer
Daniel P Hollern, Cristina M Contreras, Stephanie Dance-Barnes, et al.
BMC Genomics
|
April 29, 2004
Universal Reference RNA as a standard for microarray experiments
Natalia Novoradovskaya, Michael L Whitfield, Lee S Basehore, et al.
Oncotarget
|
December 20, 2017
Differential response to exercise in claudin-low breast cancer
Oliver K Glass, Michelle Bowie, Julie Fuller, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
Current Protocols in Pharmacology
|
March 21, 2016
Overview of Genetically Engineered Mouse Models of Distinct Breast Cancer Subtypes
Jerry Usary, David Brian Darr, Adam D Pfefferle, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
May 17, 2012
Dietary energy balance modulates epithelial-to-mesenchymal transition and tumor progression in murine claudin-low and basal-like mammary tumor models
Sarah M Dunlap, Lucia J Chiao, Leticia Nogueira, et al.
Genes & Cancer
|
March 15, 2013
Targeting the PyMT Oncogene to Diverse Mammary Cell Populations Enhances Tumor Heterogeneity and Generates Rare Breast Cancer Subtypes
Brittni A Smith, Dawne N Shelton, Collin Kieffer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2006
Estrogen-regulated genes predict survival in hormone receptor-positive breast cancers
Daniel S Oh, Melissa A Troester, Jerry Usary, et al.
Cancer Cell
|
May 5, 2009
CDK inhibitor p18(INK4c) is a downstream target of GATA3 and restrains mammary luminal progenitor cell proliferation and tumorigenesis
Xin-Hai Pei, Feng Bai, Matthew D Smith, et al.
NPJ Breast Cancer
|
July 28, 2017
Metabolic reprogramming underlies metastatic potential in an obesity-responsive murine model of metastatic triple negative breast cancer
Ciara H O'Flanagan, Emily L Rossi, Shannon B McDonell, et al.
Plos One
|
June 16, 2011
The role of calcineurin/NFAT in SFRP2 induced angiogenesis--a rationale for breast cancer treatment with the calcineurin inhibitor tacrolimus
Sharareh Siamakpour-Reihani, Joseph Caster, Desh Bandhu Nepal, et al.
Breast Cancer Research and Treatment
|
November 29, 2018
A mouse model featuring tissue-specific deletion of p53 and Brca1 gives rise to mammary tumors with genomic and transcriptomic similarities to human basal-like breast cancer
Daniel P Hollern, Cristina M Contreras, Stephanie Dance-Barnes, et al.
BMC Genomics
|
April 29, 2004
Universal Reference RNA as a standard for microarray experiments
Natalia Novoradovskaya, Michael L Whitfield, Lee S Basehore, et al.
Oncotarget
|
December 20, 2017
Differential response to exercise in claudin-low breast cancer
Oliver K Glass, Michelle Bowie, Julie Fuller, et al.
Page
of 2